ALOX5 and nonpapillary renal cell carcinoma: Moreover, 5-LOX was frequently overexpressed in pVHL-reduced and in VEGF-positive ccRCC tumors, which as discussed in the introduction, represent two frequent alterations in ccRCC [164].